JAK
Janus kinases (JAKs), belonging to a distinct family of tyrosine kinases, are non-receptor tyrosine kinases that transduce signals of cytokine receptors via diverse signal transduction pathways. Mammalian JAK family consists of four structurally similar members, JAK1, JAK2, JAK3 and Tyrosine kinase 2 (TYK2), which are characterized by containing seven JAK homology (JH) domains. The presence of JH1 and JH2 domains is the most intriguing feature of JAK proteins. JH1 domain is the main catalytic domain; while JH2 is usually considered as a catalytically inactive pseudokinase domain. However, results of recent studies have shown that JH2 acts as a dual-specificity protein kinase to phosphorylate two regulatory sites (Ser523 and Tyr570) in JAK2.
Products for JAK
- Cat.No. 产品名称 Information
-
GC19368
Upadacitinib
乌帕替尼; ABT-494
A JAK1 inhibitor -
GC19334
Solcitinib
索西替尼; GSK-2586184; GLPG-0778
A JAK1 inhibitor - GC19320 SAR-20347 A JAK family kinase inhibitor
-
GC19288
PF-06651600
PF-06651600
PF-06651600 (PF-06651600) 是一种具有口服活性的选择性 JAK3 抑制剂,IC50 为 33.1 nM。 -
GC19204
Itacitinib
伊他替尼,INCB039110
A JAK1 inhibitor -
GC10341
Peficitinb (ASP015K, JNJ-54781532)
培菲替尼,ASP015K; JNJ-54781532
A JAK inhibitor -
GC16875
FLLL32
(2E,2'E)-1,1'-环己基亚基二[3-(3,4-二甲氧基苯基)-2-丙烯-1-酮]
An inhibitor of JAK2/STAT3 signaling - GC11652 CHZ868 CHZ868 是一种 II 型 JAK2 抑制剂,在 EPOR JAK2 WT Ba/F3 细胞中的 IC50 为 0.17 μM。
-
GC14938
PF-03394197(Oclacitinib)
奥拉替尼
A JAK family kinase inhibitor -
GC10770
Decernotinib(VX-509)
迪西替尼
A selective JAK3 inhibitor - GC14857 LFM-A13 A BTK inhibitor
-
GC11209
Cerdulatinib (PRT062070)
赛度替尼,PRT062070; PRT2070
A dual inhibitor of Syk and JAKs - GC17222 GLPG0634 analogue GLPG0634 类似物 (Compoun 176) 是一种广谱 JAK 抑制剂,对 JAK1、JAK2 和 JAK3 的 IC50 值 <100 nM。
-
GC12579
GLPG0634
非戈替尼,GLPG0634
A JAK1 inhibitor -
GC14676
Pacritinib (SB1518)
帕克替尼
An equipotent inhibitor of FLT3 and JAK2 - GC17762 NSC 33994 NSC 33994 (G6) 是一种选择性 JAK2 抑制剂,IC50 为 60 nM。
-
GC15125
ZM 449829
2-萘乙烯基酮
An inhibitor of JAK3 -
GC16584
TCS 21311
NIBR3049
A JAK3 inhibitor -
GC12118
SD 1008
SD 1008 是一种有效的 JAK 抑制剂。 SD 1008 抑制 STAT3、JAK2 和 Src 的酪氨酰磷酸化。 SD 1008 还降低 STAT3 依赖性荧光素酶活性。 SD 1008 通过直接阻断 JAK-STAT3 信号通路增强紫杉醇诱导的卵巢癌细胞凋亡。
-
GC17033
Lestaurtinib
来他替尼; CEP-701; KT-5555
A potent JAK2 and PRK1 kinase inhibitor -
GC13347
Cucurbitacin I
葫芦素I,Elatericin B; JSI-124; NSC-521777
An inhibitor STAT3/JAK signaling -
GC15391
Cercosporamide
尾孢素酰胺,(-)-Cercosporamide
A potent inhibitor of fungal Pkc1 and mammalian Mnk isoforms
-
GC17055
1,2,3,4,5,6-Hexabromocyclohexane
1,2,3,4,5,6-六溴化环己烷
1,2,3,4,5,6-六溴环己烷(1,2,3,4,5,6-Hexabromocyclohexane)直接抑制JAK2激酶结构域内的口袋,抑制自身磷酸化。 -
GC14327
XL019
XL-019;XL 019
A potent, bioavailable JAK2 inhibitor -
GC15956
WHI-P97
4-(3',5'-二溴-4-羟基苯基)氨基-6,7-二甲氧基喹唑啉,WHI-P-97;WHI P97
WHI-P97 是一种有效的选择性 JAK-3 抑制剂。 -
GC12064
SB1317
14-甲基-20-氧杂-5,7,14,27-四氮杂四环[19.3.1.1(2,6).1(8,12)]二十七碳-1(25),2,4,6(27),8,10,12(26),16,21,23-十烯,TG02;SB 1317;TG 02;SB-1317;TG-02
A multi-kinase inhibitor -
GC16124
Ruxolitinib phosphate
鲁索利替尼磷酸盐,INCB018424 phosphate;INCB 018424 phosphate;INCB-018424 phosphate;Ruxolitinib
A potent and selective JAK1/JAK2 inhibitor -
GC11525
Pyridone 6
吡啶酮6
吡啶酮 6 抑制 Jak3,K(I)=5 nM; Pyridone 6 还抑制 Jak 家族成员 Tyk2 和 Jak2,IC(50)=1 nM 和 Jak1,IC(50)=15 nM。 -
GC13229
NVP-BSK805
BSK 805;BSK-805;BSK805;NVP-BSK 805
A potent, selective JAK2 inhibitor
-
GC14671
JANEX-1
4-(4'-羟基苯基)氨基-6,7-二甲氧基喹唑啉,WHI-P131;Janex 1;WHI-P 131
A selective JAK3 inhibitor -
GC13826
JAK2 Inhibitor V, Z3
Z3; NSC 42834;1-Butanone, 2-methyl-1-phenyl-4-(2-pyridinyl)-2-[2-(2-pyridinyl)ethyl]-
A selective inhibitor of the autophosphorylation of wild type and V617F mutant forms of JAK -
GC16468
CYT387 sulfate salt
N-(氰基甲基)-4-[2-[[4-(4-吗啉基)苯基]氨基]-4-嘧啶基]苯甲酰胺硫酸盐(1:2),CYT-387 sulfate;CYT 387 sulfate
A potent inhibitor of JAK1 and JAK2 -
GC13830
Baricitinib phosphate
磷酸巴瑞克替尼; LY3009104 phosphate; INCB028050 phosphate
A JAK1 and JAK2 inhibitor -
GC11572
Bardoxolone methyl
甲基巴多索隆; RTA 402; NSC 713200; CDDO Methyl ester
A synthetic triterpenoid with potent anticancer and antidiabetic activity - GC12454 BMS-911543 A potent, selective JAK2 inhibitor
- GC10638 AT9283 A broad spectrum kinase inhibitor
-
GC14245
ZM 39923 HCl
3-[异丙基(苄基)氨基]-1-(2-萘基)-1-丙酮盐酸盐
A potent inhibitor of JAK3 -
GC15589
WHI-P154
2-溴-4-(6,7-二甲氧基喹唑啉-4-基氨基)苯酚
A JAK3 inhibitor -
GC17020
S-Ruxolitinib (INCB018424)
S-鲁索替尼,S-Ruxolitinib; INCB18424
鲁索替尼 S 对映体是鲁索替尼的 S 对映体。鲁索替尼 S 对映异构体是一种 JAK 抑制剂 -
GC13848
LY2784544
Gandotinib
Potent inhibitor of JAK2 -
GC12083
CEP-33779
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺,CEP 33779,CEP33779
A potent, orally available inhibitor of JAK2 -
GC10035
TG101209
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺,TG-101209
An inhibitor of JAK2, FLT3, RET, and JAK3 -
GC13433
AZ 960
5-氟-2-[[(1S)-1-(4-氟苯基)乙基]氨基]-6-[(5-甲基-1H-吡唑-3-基)氨基]-3-吡啶腈,AZ-960,AZ960
A JAK2 inhibitor -
GC17050
CYT387
莫洛替尼,Cyt-387,MOMELOTINIB,CYT 387,CYT 11387
A potent inhibitor of JAK1 and JAK2 -
GC14844
Baricitinib (LY3009104, INCB028050)
巴瑞替尼; LY3009104; INCB028050
A JAK1 and JAK2 inhibitor -
GC15980
WP1066
(2E)-3-(6-溴-2-吡啶基)-2-氰基-N-[(1S)-1-苯基乙基]-2-丙烯酰胺
An inhibitor of STAT3
-
GC16828
Tofacitinib (CP-690550,Tasocitinib)
托法替尼; Tasocitinib; CP-690550
Tofacitinib (CP-690550,Tasocitinib) 是一种口服的 JAK3/2/1 抑制剂,IC50 分别为 1、20 和 112 nM。 -
GC12504
AZD1480
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺,AZD 1480
A potent JAK2 inhibitor -
GC14324
TG101348 (SAR302503)
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺,Tg-101348,SAR-302503
A JAK2 inhibitor -
GC17586
Tofacitinib (CP-690550) Citrate
枸橼酸托法替尼; Tasocitinib citrate; CP-690550 citrate
A pan-JAK inhibitor